Chandan Healthcare Limited — Investor Meet, 02-12-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Chandan Healthcare presented its H1 FY26 results at a group investor meet, showcasing strong performance. Revenue climbed 23.38% to ₹137.49 Cr, with EBITDA surging 43.98% to ₹29.98 Cr (21.81% margin) and PAT up 46.59% to ₹15.60 Cr (11.35% margin). Growth was driven by volume, business mix, and cost efficiency.

The company is expanding with new diagnostic centers in Patna, Lucknow, and Ayodhya. A strategic partnership with Jeena Sikho Lifecare will establish exclusive diagnostic services pan-India. Chandan plans 100 labs and 1,000 franchises in three years, targeting sustainable growth through integrated healthcare and digital platforms. Management remains confident in future expansion.